Jafron Biomedical
Jafron Biomedical Co Ltd is a Chinese medical technology company specializing in hemoperfusion devices and blood purification products. The company designs, manufactures, and markets hemoperfusion cartridges, resin adsorption columns, and blood purification equipment for treating acute poisoning, uremia, liver failure, and severe inflammation. Main revenue drivers comprise global commercial sales of hemoperfusion cartridges, blood purification equipment, and single-use disposable consumables to hospital networks. Jafron Biomedical serves nephrologists, intensive care units, emergency departments, and hospital hemodialysis centers across China, Europe, Asia, and Latin America. The company holds a market-leading global position in disposable hemoperfusion cartridge manufacturing for blood purification. Headquartered in Zhuhai, Guangdong, China, it is listed on the ChiNext market of the Shenzhen Stock Exchange.
2 of the funds FundTelligence covers report a position in Jafron Biomedical.
- Legal name
- Jafron Biomedical Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 2
Funds holding Jafron Biomedical
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.0 % (full portfolio disclosed, September 2026)